Upgrade to SI Premium - Free Trial

Earnings preview: Bernstein sees ‘clear potential for further upside’ in this stock

August 5, 2026 4:04 AM
Bernstein raised its price target on a major pharmaceutical company to $1,385 from $1,300 on Monday, maintaining an Outperform rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Hot List Hot List Pro